Discovery Laboratories Enterprise Value:
45.36M for May 17, 2013Discovery Laboratories Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 45.36M |
| May 16, 2013 | 45.36M |
| May 15, 2013 | 46.24M |
| May 14, 2013 | 45.80M |
| May 13, 2013 | 47.11M |
| May 10, 2013 | 45.36M |
| May 9, 2013 | 51.49M |
| May 8, 2013 | 47.99M |
| May 7, 2013 | 49.74M |
| May 6, 2013 | 50.61M |
| May 3, 2013 | 52.36M |
| May 2, 2013 | 50.17M |
| May 1, 2013 | 53.24M |
| April 30, 2013 | 53.68M |
| April 29, 2013 | 55.43M |
| April 26, 2013 | 54.99M |
| April 25, 2013 | 56.74M |
| April 24, 2013 | 57.18M |
| April 23, 2013 | 57.18M |
| April 22, 2013 | 57.18M |
| April 19, 2013 | 57.61M |
| April 18, 2013 | 55.86M |
| April 17, 2013 | 56.74M |
| April 16, 2013 | 57.18M |
| April 15, 2013 | 60.68M |
| April 12, 2013 | 84.31M |
| April 11, 2013 | 83.00M |
| April 10, 2013 | 79.06M |
| April 9, 2013 | 76.00M |
| April 8, 2013 | 76.43M |
| April 5, 2013 | 77.31M |
| April 4, 2013 | 78.18M |
| April 3, 2013 | 76.00M |
| April 2, 2013 | 79.50M |
| April 1, 2013 | 80.81M |
| March 28, 2013 | 73.09M |
| March 27, 2013 | 75.71M |
| March 26, 2013 | 76.15M |
| March 25, 2013 | 76.58M |
| March 22, 2013 | 74.84M |
| March 21, 2013 | 76.15M |
| March 20, 2013 | 75.71M |
| March 19, 2013 | 76.15M |
| March 18, 2013 | 73.96M |
| March 15, 2013 | 77.46M |
| March 14, 2013 | 80.51M |
| March 13, 2013 | 78.77M |
| March 12, 2013 | 86.19M |
| March 11, 2013 | 89.24M |
| March 8, 2013 | 88.81M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
DSCO Enterprise Value Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | 1.003B |
| Achillion Pharmaceuticals | 605.86M |
| Exelixis | 760.59M |
DSCO Enterprise Value Rankings
| Overall |
51st percentile 3872 of 8002 |
| Sector |
30th percentile 451 of 650 in Healthcare |
| Industry |
32nd percentile 160 of 237 in Biotechnology |
DSCO Enterprise Value Range, Past 5 Years
| Minimum | 14.63M | Mar 14 2011 |
| Maximum | 231.71M | Apr 15 2009 |
| Average | 69.89M |
